KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Common Equity (2016 - 2025)

Exact Sciences has reported Common Equity over the past 16 years, most recently at $2.4 billion for Q4 2025.

  • Quarterly Common Equity changed 0.05% to $2.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 billion through Dec 2025, changed 0.05% year-over-year, with the annual reading at $2.4 billion for FY2025, 0.05% changed from the prior year.
  • Common Equity was $2.4 billion for Q4 2025 at Exact Sciences, down from $2.5 billion in the prior quarter.
  • Over five years, Common Equity peaked at $3.6 billion in Q1 2021 and troughed at $2.4 billion in Q1 2025.
  • The 5-year median for Common Equity is $3.1 billion (2023), against an average of $3.0 billion.
  • Year-over-year, Common Equity soared 99.78% in 2021 and then dropped 23.62% in 2024.
  • A 5-year view of Common Equity shows it stood at $3.4 billion in 2021, then decreased by 10.17% to $3.0 billion in 2022, then rose by 3.36% to $3.1 billion in 2023, then dropped by 23.62% to $2.4 billion in 2024, then dropped by 0.05% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Common Equity are $2.4 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.5 billion (Q2 2025).